SlideShare a Scribd company logo
1 of 26
Download to read offline
High Pressure Refolding
as an Alternative Technology in Protein Manufacturing
Linda Gombos
University of Natural Resources and Life Sciences, Vienna • Boehringer Ingelheim RCV
Vienna • Austria
06.08.2015
Protein Refolding
High Pressure Refolding - The Bioprocessing Summit 2015
E. coli: high-yield protein expression
↔ Drawback: dense aggregates (IB) → refold to gain biological activity
Mechanism of High Pressure Treatment
High Pressure Refolding - The Bioprocessing Summit 2015
Main charachteristics of
pressure
Effects on protein stability
Densification effect
High pressure treatment favors
reactions that decrease the volume
of a system
Protein aggregates are less dense
than native proteins
→ aggregate dissociation and
formation of native, more compact
structures
Low energy
High pressure only affects weak
chemical bonds
Hydrogen bonding and secondary
structures are not affected by
elevated pressures
→ Solubilization and refolding
without first denaturing the protein
Establishment of the High Pressure Technology at
Boehringer Ingelheim RCV in Cooperation with BaroFold
High Pressure Refolding - The Bioprocessing Summit 2015
2011-2012: Feasibility study with 6 Proteins at
BaroFold (Aurora, Colorado, USA)
2013-2015: Installation of a high pressure reactor
at Process Science Austria
Test an unlimited number of molecules at
laboratory scale (1 mL-150 mL)
10 L cGMP-Reactor
Production of material for toxicological and clinical
studies
Large scale reactor (up to 525 L)
Substantial investment (new building)
Aims
• Evaluate high pressure refolding
 For our specific manufactured molecular formats on a variety of model proteins
 Develop experimental approach for fast optimization of process parameters
 Compare structure, stability, and activity of the protein variants refolded with high
pressure vs. conventional methods
 Identify potential economic benefits of high pressure compared with conventional
refolding
• Evaluate high pressure for the dissolution of soluble protein aggregates
 Using process-related aggregates of a relevant model protein
 Show that solubilized monomers have native structure
High Pressure Refolding - The Bioprocessing Summit 2015
Experimental Approach for Optimization of
Process Parameters
• Refolding yield: amount of soluble/affinity-captured protein determined
• Versatile method needed  suitable for all model proteins and buffers:
SDS-PAGE (percent error 13-15%)
• First challenge in protein refolding: to limit meaningful experimental space
High Pressure Refolding - The Bioprocessing Summit 2015
2-level factorial design
• Yield may tend to 0
at extremes of a factor
A
B
„Intuitive raster“
• For 3 levels of 5 factors
35=243 runs
A
B
Optimal design
• Requires the smallest
number of runs
A
B
Experimental Approach for Optimization of
Process Parameters
Initial screen (pH, urea, arginine, redox) to limit experimental space
Optimization of basic buffer components
Additive screen
Optimization of other parameters (e.g. Fab chain ratio, additive interactions)
Protein concentration and refolding time screen to optimize throughput
Scale-up and purification
High Pressure Refolding - The Bioprocessing Summit 2015
Example for Process Optimization  Fc-Fusion Protein
Design-Expert® Software
Correlation: 0.129
1
6
11
16
21
26
31
36
41
46
51
0
5
10
15
20
Run
Yield(%)
High Pressure Refolding - The Bioprocessing Summit 2015
Initial screen at 2 g/L
pH 8-10
Urea 0-2 M
Tris 0.05-1 M
Arg 0-0.5 M
Cysteine 0-4 mM
Cystine 0-4 mM
Parameter optima
pH not significant
→ set to 9.5
2 M Urea
1 MTris
0.4 M Arg
3 mM Cysteine
0 mM Cystine
Reduced quadratic model
R-Squared 0.6625
Adj R-Squared 0.5935
Pred R-Squared 0.4851
Adeq Precision 10.374
Design-Expert® Software
Factor Coding: Actual
Original Scale
Yield (%)
16.3218
0
X1 = E: Cysteine
X2 = F: Cystine
Actual Factors
A: pH = 9.00
B: Tris = 1.00
C: Urea = 2.00
D: Arg = 0.40
0.0
1.0
2.0
3.0
4.0
0.0
1.0
2.0
3.0
4.0
0
5
10
15
20
25
30
Yield(%)
E: Cysteine (mM)
F: Cystine (mM)
Design-Expert® Software
Factor Coding: Actual
Original Scale
Yield (%)
16.3218
0
X1 = B: Tris
X2 = D: Arg
Actual Factors
A: pH = 9.00
C: Urea = 2.00
E: Cysteine = 3.08
F: Cystine = 1.06
0.00
0.10
0.20
0.30
0.40
0.50
0.05
0.15
0.24
0.34
0.43
0.53
0.62
0.71
0.81
0.90
1.00
0
5
10
15
20
25
30
Yield(%)
B: Tris (M)
D: Arg (M)
Example for Process Optimization  Fc-Fusion Protein
High Pressure Refolding - The Bioprocessing Summit 2015
Additive screen
at 2 g/L
At optimal conditions
from initial screen
Results
Major improvement of
yield by applying
results of initial screen
No significant further
improvement by
additives ↔
candidates
A d d itiv e s
Yield(%)
B
a
s
e1
lo
w1
h
ig
h2
lo
w2
h
ig
h3
lo
w3
h
ig
h
4
5
6
7
8
9
1
0
1
1
1
2
1
3
1
4
1
5
lo
w
1
5
h
ig
h
1
6
lo
w
1
6
h
ig
h
1
7
lo
w
1
7
h
ig
h
1
8
1
9
2
0
lo
w
2
0
h
ig
h
0
1 0
2 0
3 0
4 0
S a lts D e te rg e n ts O rg a n ic co m p o u n d s
Example for Process Optimization  Fc-Fusion Protein
High Pressure Refolding - The Bioprocessing Summit 2015
Additive screen
at 8 g/L
Candidates alone and
in combination
Additive and pH screen
at 8 g/L
Results
Additive 15 improves
yields at higher protein
concentrations
Higher yields at pH 8.5
A d d itives
Yield(%)
B
a
s
e1
3
lo
w
1
3
h
ig
h1
5
lo
w
1
5
h
ig
h
4
6
1
2
1
3
lo
w
+
1
5
lo
w
1
3
lo
w
+
1
5
h
ig
h
1
3
lo
w
+
4
1
3
lo
w
+
6
1
3
lo
w
+
1
2
1
5
lo
w
+
4
1
5
lo
w
+
6
1
5
lo
w
+
1
2
1
5
h
ig
h
+
4
1
5
h
ig
h
+
6
1
5
h
ig
h
+
1
2
0
5
1 0
1 5
2 0
A d d itiv e s
Yield(%)
1
5
h
ig
h
1
5
h
ig
h
+
6
1
5
h
ig
h
+
1
21
5
h
ig
h
+
1
3
lo
w1
5
lo
w
+
1
3
lo
w
0
1 0
2 0
3 0
4 0
p H 9 .5
p H 8 .5
High Pressure Refolding Is Readily Scalable
• 1 mL caissons → 5-50 mL syringes → ca. 140 mL bioprocess bags
High Pressure Refolding - The Bioprocessing Summit 2015
scFv Affinity scaffold
200
66
55
22
14
116
97
kDa
Red. IB 140 mL
37
31
6
3.5
1mL
1mL
1mL
Std.
200
66
55
22
14
116
97
kDa
37
31
6
1mL
1mL
1mL
ReducedIB
5mL
140mL
Protein Purification
High Pressure Refolding - The Bioprocessing Summit 2015
Affinity scaffoldFab scFv
Affinity (ProteinA)
CIEX
Affinity (ProteinA)
CIEX
CIEX
S E C H P L C
T im e (m in )
A214(mAbs)
4 8 1 2 1 6
-3 0 0
0
3 0 0
6 0 0
9 0 0
1 2 0 0
C h a o tro p e
H ig h p re s su re
14
200
66
55
22
6
3.5
116
97
kDa
37
31
Chaotrope
Highpressure
S E C H P L C
T im e (m in )
A214(mAbs)
4 8 1 2 1 6
-1 0 0
0
1 0 0
2 0 0
3 0 0
4 0 0
5 0 0
C h a o tro p e
H ig h p re s su re
14
200
66
55
22
6
116
97
kDa
37
31
Chaotrope
Highpressure
S E C H P L C
T im e (m in )
A214(mAbs)
4 8 1 2 1 6
-1 0 0
0
1 0 0
2 0 0
3 0 0
4 0 0
C h a o tro p e
H ig h p re s su re
14
200
66
55
22
6
3.5
116
97
kDa
37
31
Chaotrope
Highpressure
Chaotrope: ca. 94%
High pressure: ca. 96%
Chaotrope: ca. 94%
High pressure: ca. 95%
Chaotrope: 41-49%
High pressure: 50-56%
Comparison of Protein Stability and Structure
High Pressure Refolding - The Bioprocessing Summit 2015
Affinity scaffoldFab scFv
D S C
T e m p e ra tu re (°C )
Cp(kcal/mol/°C)
0 2 0 4 0 6 0 8 0 1 0 0
-1 0
0
1 0
2 0
3 0
4 0
5 0
H ig h p re s su re
C h a o tro p e
C D s p e c tru m
 (n m )
[](degcm
2
dmol
-1
)
1 8 0 2 0 0 2 2 0 2 4 0 2 6 0
-6 .0 1 0 5
-4 .0 1 0 5
-2 .0 1 0 5
0
2 .0 1 0 5
4 .0 1 0 5
C h a o tro p e
H ig h p re s su re
D S C
T e m p e ra tu re (°C )
Cp(kcal/mol/°C)
0 2 0 4 0 6 0 8 0 1 0 0
-5
0
5
1 0
1 5
C h a o tro p e
H ig h p re s su re
C D s p e c tru m
 (n m )
[](degcm
2
dmol
-1
)
1 8 0 2 0 0 2 2 0 2 4 0 2 6 0
-4 .0 1 0 5
-2 .0 1 0 5
0
2 .0 1 0 5
4 .0 1 0 5
C h a o tro p e
H ig h p re s su re
C D s p e c tru m
 (n m )
[](degcm
2
dmol
-1
)
1 8 0 2 0 0 2 2 0 2 4 0 2 6 0
-1 .5 1 0 6
-1 .0 1 0 6
-5 .0 1 0 5
0
5 .0 1 0 5
1 .0 1 0 6
C h a o tro p e
H ig h p re s su re
D S C
T e m p e ra tu re (°C )
Cp(kcal/mol/°C)
0 2 0 4 0 6 0 8 0 1 0 0
-2 0
0
2 0
4 0
6 0
C h a o tro p e
H ig h p re s su re
Comparison of Activity  Fc-Fusion Protein
High Pressure Refolding - The Bioprocessing Summit 2015
Strucural studies Fc-receptor binding by SPR
-50
0
50
100
150
200
250
-50 0 50 100 150 200 250 300 350 400
RU
Response
Tim e s
-20
0
20
40
60
80
100
120
140
160
180
-50 0 50 100 150 200 250 300 350 400
RU
Response
Tim e s
-50
0
50
100
150
200
250
-50 0 50 100 150 200 250 300 350 400
RU
Response
Tim e s
Sensorsurface Fc-fusion / IgG
FcRn
Fc-fusion - chaotrope
Fc-fusion - high pressure
Control - IgG
Kd = 35  11 nM
Kd = 46  8 nM
Kd = 63  3 nM
D S C
T e m p e ra tu re (°C )
Cp(kcal/mole/°C)
2 0 4 0 6 0 8 0 1 0 0
-5
0
5
1 0
1 5
2 0
2 5
C h a o tro p e
H ig h p re s s u re
C D s p e c tru m
W a v e le n g th (n m )
[](degcm
2
dmol
-1
)
2 0 0 2 2 0 2 4 0 2 6 0
-3 .0 1 0 5
-2 .0 1 0 5
-1 .0 1 0 5
0
1 .0 1 0 5
2 .0 1 0 5
3 .0 1 0 5
C h a o tro p e
H ig h p re s s u re
Low Population of Aggregate-prone Intermediates
Increases Refolding Yields at High Protein Concentrations
High Pressure Refolding - The Bioprocessing Summit 2015
M axim al refolding yields
P ro te in c o n c e n tra tio n (g /L )
Yield(%)
0 5 1 0 1 5
0
2 0
4 0
6 0
8 0
C h a o tro p e
H ig h p re s su re
M axim al produ ctivity
P ro te in c o n c e n tra tio n (g /L )
Productivity(g/L/h)
0 .1 1 1 0 1 0 0
0 .0 1
0 .1
1
1 0
C h a o tro p e
H ig h p re s su re
• Fc-fusion protein refolded conventionally and with high pressure
High Pressure Refolding Increases Productivity
Molecule class Conventional
refolding
High pressure
refolding
Increase in
productivity
Fabs
15% at 0.8 g/L in 30 h 20% at 2 g/L in 6+24 h* 17x
15% at 0.2 g/L in 16 h 6% at 2 g/L in 6 h 11x
3 Fabs not refoldable 3 Fabs not refoldable -
scFv 80% at 0.2 g/L in 8 h 40% at 6 g/L in 16 h 8x
Other affinity scaffolds
80% at 0.9 g/L in 18 h 50% at 4 g/L in 6 h 8x
10% at 0.1 g/L in 24 h 5% at 2 g/L in 8 h 30x
50% at 1.2 g/L in 24 h 60% at 2 g/L in 2 h 24x
Fc-fusions
35% at 0.8 g/L in 3 h 20% at 15 g/L in 2 h 16x
15% at 0.7 g/L in 5 h 50% at 4 g/L in 6 h 16x
Other fusion proteins
45% at 1 g/L in 24 h 30% at 30 g/L in 1+8 h* 480x
20% at 1.2 g/L in 12 h 35% at 10 g/L in 1+20 h* 175x
45% at 2 g/L in 14 h 50% at 15 g/L in 1+10 h* 117x
High Pressure Refolding - The Bioprocessing Summit 2015
*Time in refolding vessel used for the calculation of productivity
Large-scale Manufacturing Feasibility for
2 kg Cleaved and Purified Fusion Protein
High Pressure Refolding - The Bioprocessing Summit 2015
Protein mass: 48 kg
Titer: 12 g/L
Volume: 3,700 L
3 columns
Overall yield: 50%
Target protein: 2 kg
Step yield: 90%
Protein mass: 44 kg
Step yield: 90%
Protein mass: 27 kg
Target protein: 4 kg
Fusion protein: 12 kg
45% yield at 1 g/L in 24 h
27 kg protein in 27,000 L
Max. capacity at BI: 35,000 L
2 cycles at full capacity
Target protein: 4 kg
Fusion protein: 12 kg
30% yield at 30 g/L in 1+10 h
40 kg protein in 1,300 L
Max. capacity : 525 L
3 cycles within 1 day
Fermentation
IB recovery
Purification
Fill/finish
Solubilization
Refolding by
dilution
Refolding by
pressure
treatment
Step yield: 90%
Protein mass: 30 kg
Protein mass: 30 kg
Titer: 12 g/L
Volume: ca. 2,500 L
Dissolution of Soluble Protein Aggregates
High Pressure Refolding - The Bioprocessing Summit 2015
• Origin of soluble aggregates:
 Mammalian cell expression
 Protein processing and purification
• Fields of application:
 Early in downstream processing
dissolve large amounts of soluble
aggregates formed during expression
 Polishing step
solubilize trace amounts of aggregates
to meet quality criteria
• Model protein:
 Expressed in CHO cells
 Capture pool contains ca. 12%
aggregates
S E C H P L C c h ro m a to g ra m
T im e (m in )
A214(mAU)
2 4
-1 0 0
0
1 0 0
2 0 0
3 0 0
4 0 0
5 0 0
4 6 8 1 0 1 2
A g g re g a te s
M o d ifie d m o n o m e rs
N a tiv e m o n o m e rs
S E C H P L C c h ro m a to g ra m
T im e (m in )
A214(mAU)
2 4
-1 0 0
0
1 0 0
2 0 0
3 0 0
4 0 0
5 0 0
4 6 8 1 0 1 2
Effects of Pressure and pH
High Pressure Refolding - The Bioprocessing Summit 2015
p HAggregatecontent(%)
6 .0 7 .0 8 .0 9 .0
0
5
1 0
1 5 A m b ie n t p re s s u re
2 5 0 0 b a r
P re s s u re
Aggregatecontent(%)
2 0 0 0 b a r 3 0 0 0 b a r
0
5
1 0
1 5 A m b ie n t p re s s u re
H ig h p re s s u re
Additives Do Not Improve the Solubilization of Aggregates
High Pressure Refolding - The Bioprocessing Summit 2015
A d d itiv e
%aggregatesHP/%aggregatesAP
b
a
s
e
1
2
3
4
5
6
7
89
lo
w9
h
ig
h
1
0
lo
w
1
0
h
ig
h
1
1
lo
w
1
1
h
ig
h
1
2
lo
w
1
2
h
ig
h
1
3
lo
w
1
3
h
ig
h
1
4
lo
w
1
4
h
ig
h
1
5
1
6
lo
w
1
6
h
ig
h
0 .0 0
0 .2 5
0 .5 0
0 .7 5
1 .0 0
1 .2 5
1 .5 0
D e te rg e n ts O rg a n ic c o m p o u n d s
Effects of Pressurization Time and Protein Concentration
High Pressure Refolding - The Bioprocessing Summit 2015
P ro te in c o n c e n tra tio n (g /L )
Foldreductionofaggregatecontent
0 .5 1 2 4
0
1
2
3
4
1 6 h
1 h
T im e (m in )
A214(mAU)
2 4
-1 0 0
0
1 0 0
2 0 0
3 0 0
4 0 0
5 0 0
4 6 8 1 0 1 2
a g g re g a te s
S E C c h ro m a to g ra m s
A m b ie n t p re ssu re
3 0 0 0 b a r
P ro te in c o n c e n tra tio n (g /L )
Aggregatecontent(%)
0 .5 1 2 4 6
0
5
1 0
1 5
A m b ie n t p re s s u re
1 h a t 3 0 0 0 b a r
Are the monomers which were
dissolved from aggregates
identical to the monomers
which have always been
monomers?www.clipartbest.com
Enrichment of Monomers Dissolved from Aggregates
High Pressure Refolding - The Bioprocessing Summit 2015
HIC regeneration pool
SEC (S200) purification
of aggregates
High pressure dissolution
of aggregates
SEC (S200) purification
of monomers
S E C H P L C c h ro m a to g ra m s
T im e (m in )
A214(mAU)
2 4
-1 0 0
0
1 0 0
2 0 0
3 0 0
4 0 0
5 0 0
6 0 0
4 6 8 1 0 1 2
H IC re g e n e ra tio n p e a k
S E C p u rifie d a g g re g a te s
H P tre a te d a g g re g a te s
S E C p u rifie d m o n o m e rs
R e fe re n ce
4 1 % A g g re g a te
2 0 % M o d ifie d
3 9 % M o n o m e r
8 8 % A g g re g a te
8 % M o d ifie d
4 % M o n o m e r
2 0 % A g g re g a te
1 1 % M o d ifie d
6 9 % M o n o m e r
2 % A g g re g a te
9 % M o d ifie d
8 9 % M o n o m e r
Monomers Dissolved from Aggregates Are Highly Similar
to the Reference Material
High Pressure Refolding - The Bioprocessing Summit 2015
S e c o n d a ry s tru c tu re b y C D s p e c tro s c o p y
V a w e le n g th (n m )
[](degcm
2
dmol
-1
)
2 0 0 2 2 0 2 4 0 2 6 0
-3 0 0 0 0 0
-2 0 0 0 0 0
-1 0 0 0 0 0
0
1 0 0 0 0 0
2 0 0 0 0 0
R e fe re n c e
le s s s trin g e n t c o n d itio n s
H P d is s o lv e d
le s s s trin g e n t c o n d itio n s
R e fe re n c e
m o re s trin g e n t c o n d itio n s
H P d is s o lv e d
m o re s trin g e n t c o n d itio n s
Monomers Dissolved from Aggregates Are Highly Similar
to the Reference Material
High Pressure Refolding - The Bioprocessing Summit 2015
T h e rm a l s ta b ility b y D S C
T e m p e ra tu re (°C )
Cp(kcal/mol/°C)
2 0 4 0 6 0 8 0 1 0 0
-1 0
0
1 0
2 0
3 0
R e fe re n c e
le s s s trin g e n t c o n d itio n s
H P d is s o lv e d
le s s s trin g e n t c o n d itio n s
R e fe re n c e
m o re s trin g e n t c o n d itio n s
H P d is s o lv e d
m o re s trin g e n t c o n d itio n s
T h e rm a l s ta b ility b y in trin s ic flu o re s c e n c e
T e m p e ra tu re (°C )
BCMwavelength(nm)
2 0 4 0 6 0 8 0 1 0 0
3 3 0
3 4 0
3 5 0
3 6 0
R e fe re n c e
le s s s trin g e n t c o n d itio n s
H P d is s o lv e d
le s s s trin g e n t c o n d itio n s
R e fe re n c e
m o re s trin g e n t c o n d itio n s
H P d is s o lv e d
m o re s trin g e n t c o n d itio n s
A g g re g a tio n b y lig h t s c a tte rin g
T e m p e ra tu re (°C )
SLS266(counts.nm)
2 0 4 0 6 0 8 0 1 0 0
0
5 0 0 0 0
1 0 0 0 0 0
1 5 0 0 0 0
2 0 0 0 0 0
R e fe re n c e
le s s s trin g e n t c o n d itio n s
H P d is s o lv e d
le s s s trin g e n t c o n d itio n s
R e fe re n c e
m o re s trin g e n t c o n d itio n s
H P d is s o lv e d
m o re s trin g e n t c o n d itio n s
Summary
 Evaluated high pressure for
 Refolding a variety of BI‘s model proteins
 Dissolution of soluble protein aggregates
 Inclusion body refolding:
 High pressure increases productivity compared with conventional chaotrope-based
techniques
 Structure, stability, and activity of proteins refolded with high pressure vs. conventionally
are highly comparable
 High pressure refolding is readily scalable
 High pressure can enable large-scale manufacturing
 Aggregate solubilization:
 High pressure treatment converts soluble aggregates into native-like monomers
High Pressure Refolding - The Bioprocessing Summit 2015
Acknowledgement
High Pressure Refolding - The Bioprocessing Summit 2015
• Boehringer-Ingelheim RCV
Process Science
 Susanne Schweiger
 Gerald Bieder
 Martin Kellner
 Srjib Banerjee
 Cornelia Walther
 Dean Harde
 Robert Wandl
 Matthias Berkemeyer
 Jan Schöning
 Wolfgang Buchinger
• University of Natural Resources and Life
Sciences, Vienna
 Alois Jungbauer
• BaroFold
 Matt Seefeldt

More Related Content

What's hot

Host Cell Protein Analysis - Measuring the Forest, or Counting theTrees
Host Cell Protein Analysis - Measuring the Forest, or Counting theTreesHost Cell Protein Analysis - Measuring the Forest, or Counting theTrees
Host Cell Protein Analysis - Measuring the Forest, or Counting theTreesTed Kocot
 
Hot melt extrusion with PVA: A new opportunity for challenging APIs
Hot melt extrusion with PVA: A new opportunity for challenging APIs Hot melt extrusion with PVA: A new opportunity for challenging APIs
Hot melt extrusion with PVA: A new opportunity for challenging APIs Merck Life Sciences
 
Oxidation of a Glycosylated Therapeutic Protein
Oxidation of a Glycosylated Therapeutic ProteinOxidation of a Glycosylated Therapeutic Protein
Oxidation of a Glycosylated Therapeutic ProteinKBI Biopharma
 
The Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train PlatformThe Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train PlatformMerck Life Sciences
 
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD ParadigmCustom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD ParadigmMilliporeSigma
 
Mitigating Risks through Product Characterization
Mitigating Risks through Product CharacterizationMitigating Risks through Product Characterization
Mitigating Risks through Product CharacterizationMerck Life Sciences
 
Simplification of Fed-Batch Processes Using Modified Amino Acids
Simplification of Fed-Batch Processes Using Modified Amino AcidsSimplification of Fed-Batch Processes Using Modified Amino Acids
Simplification of Fed-Batch Processes Using Modified Amino AcidsMerck Life Sciences
 
Facility Intensification and Cost Reduction using an Integrated Buffer Delive...
Facility Intensification and Cost Reduction using an Integrated Buffer Delive...Facility Intensification and Cost Reduction using an Integrated Buffer Delive...
Facility Intensification and Cost Reduction using an Integrated Buffer Delive...Merck Life Sciences
 
Octet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation StrategiesOctet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation StrategiesKBI Biopharma
 
Digestibility Study V1.2
Digestibility Study V1.2Digestibility Study V1.2
Digestibility Study V1.2?lexander Kunz
 
Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
Host Cell Protein Analysis by Mass Spectrometry | KBI BiopharmaHost Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
Host Cell Protein Analysis by Mass Spectrometry | KBI BiopharmaKBI Biopharma
 
Seminar 2 copy
Seminar 2   copySeminar 2   copy
Seminar 2 copyHau Nguyen
 
Antibodies - Key Marker Performance - July 2015
Antibodies - Key Marker Performance - July 2015Antibodies - Key Marker Performance - July 2015
Antibodies - Key Marker Performance - July 2015BBISolutions
 
Importance of Understanding the Physical State of Excipients in a Freeze Drie...
Importance of Understanding the Physical State of Excipients in a Freeze Drie...Importance of Understanding the Physical State of Excipients in a Freeze Drie...
Importance of Understanding the Physical State of Excipients in a Freeze Drie...KBI Biopharma
 
Fast-track solutions to address challenges with Host Cell Proteins in early d...
Fast-track solutions to address challenges with Host Cell Proteins in early d...Fast-track solutions to address challenges with Host Cell Proteins in early d...
Fast-track solutions to address challenges with Host Cell Proteins in early d...Merck Life Sciences
 
Polysaccharide based nanoparticles for encapsualtion and release of antineopl...
Polysaccharide based nanoparticles for encapsualtion and release of antineopl...Polysaccharide based nanoparticles for encapsualtion and release of antineopl...
Polysaccharide based nanoparticles for encapsualtion and release of antineopl...Tomsk Polytechnic University
 
API Stability in Solid Dose Formulation – the Myth of Inert Excipients
API Stability in Solid Dose Formulation – the Myth of Inert ExcipientsAPI Stability in Solid Dose Formulation – the Myth of Inert Excipients
API Stability in Solid Dose Formulation – the Myth of Inert ExcipientsMerck Life Sciences
 
Improvement in Protein A Resin Lifetime
Improvement in Protein A Resin LifetimeImprovement in Protein A Resin Lifetime
Improvement in Protein A Resin LifetimeMerck Life Sciences
 
BBI Solutions - Enzymes
BBI Solutions - EnzymesBBI Solutions - Enzymes
BBI Solutions - EnzymesBBISolutions
 
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...MilliporeSigma
 

What's hot (20)

Host Cell Protein Analysis - Measuring the Forest, or Counting theTrees
Host Cell Protein Analysis - Measuring the Forest, or Counting theTreesHost Cell Protein Analysis - Measuring the Forest, or Counting theTrees
Host Cell Protein Analysis - Measuring the Forest, or Counting theTrees
 
Hot melt extrusion with PVA: A new opportunity for challenging APIs
Hot melt extrusion with PVA: A new opportunity for challenging APIs Hot melt extrusion with PVA: A new opportunity for challenging APIs
Hot melt extrusion with PVA: A new opportunity for challenging APIs
 
Oxidation of a Glycosylated Therapeutic Protein
Oxidation of a Glycosylated Therapeutic ProteinOxidation of a Glycosylated Therapeutic Protein
Oxidation of a Glycosylated Therapeutic Protein
 
The Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train PlatformThe Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train Platform
 
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD ParadigmCustom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
 
Mitigating Risks through Product Characterization
Mitigating Risks through Product CharacterizationMitigating Risks through Product Characterization
Mitigating Risks through Product Characterization
 
Simplification of Fed-Batch Processes Using Modified Amino Acids
Simplification of Fed-Batch Processes Using Modified Amino AcidsSimplification of Fed-Batch Processes Using Modified Amino Acids
Simplification of Fed-Batch Processes Using Modified Amino Acids
 
Facility Intensification and Cost Reduction using an Integrated Buffer Delive...
Facility Intensification and Cost Reduction using an Integrated Buffer Delive...Facility Intensification and Cost Reduction using an Integrated Buffer Delive...
Facility Intensification and Cost Reduction using an Integrated Buffer Delive...
 
Octet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation StrategiesOctet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation Strategies
 
Digestibility Study V1.2
Digestibility Study V1.2Digestibility Study V1.2
Digestibility Study V1.2
 
Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
Host Cell Protein Analysis by Mass Spectrometry | KBI BiopharmaHost Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
 
Seminar 2 copy
Seminar 2   copySeminar 2   copy
Seminar 2 copy
 
Antibodies - Key Marker Performance - July 2015
Antibodies - Key Marker Performance - July 2015Antibodies - Key Marker Performance - July 2015
Antibodies - Key Marker Performance - July 2015
 
Importance of Understanding the Physical State of Excipients in a Freeze Drie...
Importance of Understanding the Physical State of Excipients in a Freeze Drie...Importance of Understanding the Physical State of Excipients in a Freeze Drie...
Importance of Understanding the Physical State of Excipients in a Freeze Drie...
 
Fast-track solutions to address challenges with Host Cell Proteins in early d...
Fast-track solutions to address challenges with Host Cell Proteins in early d...Fast-track solutions to address challenges with Host Cell Proteins in early d...
Fast-track solutions to address challenges with Host Cell Proteins in early d...
 
Polysaccharide based nanoparticles for encapsualtion and release of antineopl...
Polysaccharide based nanoparticles for encapsualtion and release of antineopl...Polysaccharide based nanoparticles for encapsualtion and release of antineopl...
Polysaccharide based nanoparticles for encapsualtion and release of antineopl...
 
API Stability in Solid Dose Formulation – the Myth of Inert Excipients
API Stability in Solid Dose Formulation – the Myth of Inert ExcipientsAPI Stability in Solid Dose Formulation – the Myth of Inert Excipients
API Stability in Solid Dose Formulation – the Myth of Inert Excipients
 
Improvement in Protein A Resin Lifetime
Improvement in Protein A Resin LifetimeImprovement in Protein A Resin Lifetime
Improvement in Protein A Resin Lifetime
 
BBI Solutions - Enzymes
BBI Solutions - EnzymesBBI Solutions - Enzymes
BBI Solutions - Enzymes
 
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...
 

Viewers also liked

Baro Fold Pep Talk 2010
Baro Fold Pep Talk 2010Baro Fold Pep Talk 2010
Baro Fold Pep Talk 2010mseefeldt
 
Sync Google Calendar with Outlook 2010 !!
Sync Google Calendar with Outlook 2010 !!Sync Google Calendar with Outlook 2010 !!
Sync Google Calendar with Outlook 2010 !!peterb8
 
Kertas kerja amsa malaysia jppel updated
Kertas kerja amsa malaysia   jppel updatedKertas kerja amsa malaysia   jppel updated
Kertas kerja amsa malaysia jppel updatedSavyN1234
 
How to add RSS Feed in MS Outlook?
How to add RSS Feed in MS Outlook?How to add RSS Feed in MS Outlook?
How to add RSS Feed in MS Outlook?peterb8
 
Common Problems with Outlook 2010
Common Problems with Outlook 2010Common Problems with Outlook 2010
Common Problems with Outlook 2010peterb8
 
Laporan eksekutif 2
Laporan eksekutif 2Laporan eksekutif 2
Laporan eksekutif 2SavyN1234
 
Laporan eksekutif
Laporan eksekutifLaporan eksekutif
Laporan eksekutifSavyN1234
 
How to Change Time Format in Outlook ?
How to Change Time Format in Outlook ?How to Change Time Format in Outlook ?
How to Change Time Format in Outlook ?peterb8
 
What is journals
What is journalsWhat is journals
What is journalspeterb8
 
Method to Print Multiple Notes on a single page
Method to Print Multiple Notes on a single pageMethod to Print Multiple Notes on a single page
Method to Print Multiple Notes on a single pagepeterb8
 
How to Create a New PST file from Old Emails?
How to Create a New PST file from Old Emails?How to Create a New PST file from Old Emails?
How to Create a New PST file from Old Emails?peterb8
 
Omgevingsloket test slideshow
Omgevingsloket test slideshowOmgevingsloket test slideshow
Omgevingsloket test slideshowjaneerdekens
 
Minit mesyuarat 2
Minit mesyuarat 2Minit mesyuarat 2
Minit mesyuarat 2SavyN1234
 

Viewers also liked (15)

Baro Fold Pep Talk 2010
Baro Fold Pep Talk 2010Baro Fold Pep Talk 2010
Baro Fold Pep Talk 2010
 
Tp addition
Tp additionTp addition
Tp addition
 
Sync Google Calendar with Outlook 2010 !!
Sync Google Calendar with Outlook 2010 !!Sync Google Calendar with Outlook 2010 !!
Sync Google Calendar with Outlook 2010 !!
 
Kertas kerja amsa malaysia jppel updated
Kertas kerja amsa malaysia   jppel updatedKertas kerja amsa malaysia   jppel updated
Kertas kerja amsa malaysia jppel updated
 
How to add RSS Feed in MS Outlook?
How to add RSS Feed in MS Outlook?How to add RSS Feed in MS Outlook?
How to add RSS Feed in MS Outlook?
 
Common Problems with Outlook 2010
Common Problems with Outlook 2010Common Problems with Outlook 2010
Common Problems with Outlook 2010
 
Laporan eksekutif 2
Laporan eksekutif 2Laporan eksekutif 2
Laporan eksekutif 2
 
Laporan eksekutif
Laporan eksekutifLaporan eksekutif
Laporan eksekutif
 
How to Change Time Format in Outlook ?
How to Change Time Format in Outlook ?How to Change Time Format in Outlook ?
How to Change Time Format in Outlook ?
 
What is journals
What is journalsWhat is journals
What is journals
 
Method to Print Multiple Notes on a single page
Method to Print Multiple Notes on a single pageMethod to Print Multiple Notes on a single page
Method to Print Multiple Notes on a single page
 
How to Create a New PST file from Old Emails?
How to Create a New PST file from Old Emails?How to Create a New PST file from Old Emails?
How to Create a New PST file from Old Emails?
 
Software testing day1
Software testing day1Software testing day1
Software testing day1
 
Omgevingsloket test slideshow
Omgevingsloket test slideshowOmgevingsloket test slideshow
Omgevingsloket test slideshow
 
Minit mesyuarat 2
Minit mesyuarat 2Minit mesyuarat 2
Minit mesyuarat 2
 

Similar to High Pressure Refolding BPS 2015 LG

Hydrolysate Characterization Technical Presentation Webinar11 2009
Hydrolysate Characterization Technical Presentation Webinar11 2009Hydrolysate Characterization Technical Presentation Webinar11 2009
Hydrolysate Characterization Technical Presentation Webinar11 2009Mason Williams
 
Process Intensification for future bioprocessing
Process Intensification for future bioprocessingProcess Intensification for future bioprocessing
Process Intensification for future bioprocessingMilliporeSigma
 
1 c.6 presentation fabianopiccinno
1 c.6 presentation fabianopiccinno1 c.6 presentation fabianopiccinno
1 c.6 presentation fabianopiccinnoAl Baha University
 
Monoclonal antibodies,Production + bioseperartion
Monoclonal antibodies,Production + bioseperartionMonoclonal antibodies,Production + bioseperartion
Monoclonal antibodies,Production + bioseperartionshadan87
 
Microbial catalysis of syngas fermentation into biofuels precursors - An expe...
Microbial catalysis of syngas fermentation into biofuels precursors - An expe...Microbial catalysis of syngas fermentation into biofuels precursors - An expe...
Microbial catalysis of syngas fermentation into biofuels precursors - An expe...Pratap Jung Rai
 
Adiabatic Reactor Analysis for Methanol Synthesis Plant Note Book Series: P...
Adiabatic Reactor Analysis for Methanol Synthesis   Plant Note Book Series: P...Adiabatic Reactor Analysis for Methanol Synthesis   Plant Note Book Series: P...
Adiabatic Reactor Analysis for Methanol Synthesis Plant Note Book Series: P...Gerard B. Hawkins
 
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...CrimsonpublishersNTNF
 
Technology Trends in Bioprocessing Purification
Technology Trends in Bioprocessing PurificationTechnology Trends in Bioprocessing Purification
Technology Trends in Bioprocessing PurificationMerck Life Sciences
 
High Throughput Bioreactor Mimetic in Early and Late Stage Process Development
High Throughput Bioreactor Mimetic in Early and Late Stage Process DevelopmentHigh Throughput Bioreactor Mimetic in Early and Late Stage Process Development
High Throughput Bioreactor Mimetic in Early and Late Stage Process DevelopmentKBI Biopharma
 
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...Waters Corporation
 
MEWE workshop 'Prospects for multiomics methods in the microbial ecology of w...
MEWE workshop 'Prospects for multiomics methods in the microbial ecology of w...MEWE workshop 'Prospects for multiomics methods in the microbial ecology of w...
MEWE workshop 'Prospects for multiomics methods in the microbial ecology of w...Aljoscha Wahl
 
Liquid Liquid Extraction - Basic Principles
Liquid Liquid Extraction - Basic PrinciplesLiquid Liquid Extraction - Basic Principles
Liquid Liquid Extraction - Basic PrinciplesGerard B. Hawkins
 
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit Tosoh
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit TosohDr. Elke Prohaska & Regina Römling BioInnovation Leader Summit Tosoh
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit TosohGBX Summits
 
BioInnovation Leader Summit Transforming Process Efficiency
 BioInnovation Leader Summit Transforming Process Efficiency BioInnovation Leader Summit Transforming Process Efficiency
BioInnovation Leader Summit Transforming Process EfficiencyGBX Summits
 
Glycos Biotechnologies.TAMU presentation_PC edits
Glycos Biotechnologies.TAMU presentation_PC editsGlycos Biotechnologies.TAMU presentation_PC edits
Glycos Biotechnologies.TAMU presentation_PC editsAllana Robertson
 
Protein Thermal Shift™ Solution Using Applied Biosystems Real-Time PCR Systems
Protein Thermal Shift™ Solution Using Applied Biosystems Real-Time PCR SystemsProtein Thermal Shift™ Solution Using Applied Biosystems Real-Time PCR Systems
Protein Thermal Shift™ Solution Using Applied Biosystems Real-Time PCR SystemsThermo Fisher Scientific
 
Inline Flocculation for Harvest and Perfusate Clarification
Inline Flocculation for Harvest and Perfusate ClarificationInline Flocculation for Harvest and Perfusate Clarification
Inline Flocculation for Harvest and Perfusate ClarificationMerck Life Sciences
 
Inline Flocculation for Harvest and Perfusate Clarification
Inline Flocculation for Harvest and Perfusate ClarificationInline Flocculation for Harvest and Perfusate Clarification
Inline Flocculation for Harvest and Perfusate ClarificationMilliporeSigma
 
An Industrial Method of Biofuel Production from Chitin
An Industrial Method of Biofuel Production from ChitinAn Industrial Method of Biofuel Production from Chitin
An Industrial Method of Biofuel Production from ChitinCharlie Pei
 

Similar to High Pressure Refolding BPS 2015 LG (20)

Hydrolysate Characterization Technical Presentation Webinar11 2009
Hydrolysate Characterization Technical Presentation Webinar11 2009Hydrolysate Characterization Technical Presentation Webinar11 2009
Hydrolysate Characterization Technical Presentation Webinar11 2009
 
Process Intensification for future bioprocessing
Process Intensification for future bioprocessingProcess Intensification for future bioprocessing
Process Intensification for future bioprocessing
 
1 c.6 presentation fabianopiccinno
1 c.6 presentation fabianopiccinno1 c.6 presentation fabianopiccinno
1 c.6 presentation fabianopiccinno
 
Food Pro Clean Line - Alan Fourie
Food Pro Clean Line - Alan FourieFood Pro Clean Line - Alan Fourie
Food Pro Clean Line - Alan Fourie
 
Monoclonal antibodies,Production + bioseperartion
Monoclonal antibodies,Production + bioseperartionMonoclonal antibodies,Production + bioseperartion
Monoclonal antibodies,Production + bioseperartion
 
Microbial catalysis of syngas fermentation into biofuels precursors - An expe...
Microbial catalysis of syngas fermentation into biofuels precursors - An expe...Microbial catalysis of syngas fermentation into biofuels precursors - An expe...
Microbial catalysis of syngas fermentation into biofuels precursors - An expe...
 
Adiabatic Reactor Analysis for Methanol Synthesis Plant Note Book Series: P...
Adiabatic Reactor Analysis for Methanol Synthesis   Plant Note Book Series: P...Adiabatic Reactor Analysis for Methanol Synthesis   Plant Note Book Series: P...
Adiabatic Reactor Analysis for Methanol Synthesis Plant Note Book Series: P...
 
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...
 
Technology Trends in Bioprocessing Purification
Technology Trends in Bioprocessing PurificationTechnology Trends in Bioprocessing Purification
Technology Trends in Bioprocessing Purification
 
High Throughput Bioreactor Mimetic in Early and Late Stage Process Development
High Throughput Bioreactor Mimetic in Early and Late Stage Process DevelopmentHigh Throughput Bioreactor Mimetic in Early and Late Stage Process Development
High Throughput Bioreactor Mimetic in Early and Late Stage Process Development
 
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
 
MEWE workshop 'Prospects for multiomics methods in the microbial ecology of w...
MEWE workshop 'Prospects for multiomics methods in the microbial ecology of w...MEWE workshop 'Prospects for multiomics methods in the microbial ecology of w...
MEWE workshop 'Prospects for multiomics methods in the microbial ecology of w...
 
Liquid Liquid Extraction - Basic Principles
Liquid Liquid Extraction - Basic PrinciplesLiquid Liquid Extraction - Basic Principles
Liquid Liquid Extraction - Basic Principles
 
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit Tosoh
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit TosohDr. Elke Prohaska & Regina Römling BioInnovation Leader Summit Tosoh
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit Tosoh
 
BioInnovation Leader Summit Transforming Process Efficiency
 BioInnovation Leader Summit Transforming Process Efficiency BioInnovation Leader Summit Transforming Process Efficiency
BioInnovation Leader Summit Transforming Process Efficiency
 
Glycos Biotechnologies.TAMU presentation_PC edits
Glycos Biotechnologies.TAMU presentation_PC editsGlycos Biotechnologies.TAMU presentation_PC edits
Glycos Biotechnologies.TAMU presentation_PC edits
 
Protein Thermal Shift™ Solution Using Applied Biosystems Real-Time PCR Systems
Protein Thermal Shift™ Solution Using Applied Biosystems Real-Time PCR SystemsProtein Thermal Shift™ Solution Using Applied Biosystems Real-Time PCR Systems
Protein Thermal Shift™ Solution Using Applied Biosystems Real-Time PCR Systems
 
Inline Flocculation for Harvest and Perfusate Clarification
Inline Flocculation for Harvest and Perfusate ClarificationInline Flocculation for Harvest and Perfusate Clarification
Inline Flocculation for Harvest and Perfusate Clarification
 
Inline Flocculation for Harvest and Perfusate Clarification
Inline Flocculation for Harvest and Perfusate ClarificationInline Flocculation for Harvest and Perfusate Clarification
Inline Flocculation for Harvest and Perfusate Clarification
 
An Industrial Method of Biofuel Production from Chitin
An Industrial Method of Biofuel Production from ChitinAn Industrial Method of Biofuel Production from Chitin
An Industrial Method of Biofuel Production from Chitin
 

High Pressure Refolding BPS 2015 LG

  • 1. High Pressure Refolding as an Alternative Technology in Protein Manufacturing Linda Gombos University of Natural Resources and Life Sciences, Vienna • Boehringer Ingelheim RCV Vienna • Austria 06.08.2015
  • 2. Protein Refolding High Pressure Refolding - The Bioprocessing Summit 2015 E. coli: high-yield protein expression ↔ Drawback: dense aggregates (IB) → refold to gain biological activity
  • 3. Mechanism of High Pressure Treatment High Pressure Refolding - The Bioprocessing Summit 2015 Main charachteristics of pressure Effects on protein stability Densification effect High pressure treatment favors reactions that decrease the volume of a system Protein aggregates are less dense than native proteins → aggregate dissociation and formation of native, more compact structures Low energy High pressure only affects weak chemical bonds Hydrogen bonding and secondary structures are not affected by elevated pressures → Solubilization and refolding without first denaturing the protein
  • 4. Establishment of the High Pressure Technology at Boehringer Ingelheim RCV in Cooperation with BaroFold High Pressure Refolding - The Bioprocessing Summit 2015 2011-2012: Feasibility study with 6 Proteins at BaroFold (Aurora, Colorado, USA) 2013-2015: Installation of a high pressure reactor at Process Science Austria Test an unlimited number of molecules at laboratory scale (1 mL-150 mL) 10 L cGMP-Reactor Production of material for toxicological and clinical studies Large scale reactor (up to 525 L) Substantial investment (new building)
  • 5. Aims • Evaluate high pressure refolding  For our specific manufactured molecular formats on a variety of model proteins  Develop experimental approach for fast optimization of process parameters  Compare structure, stability, and activity of the protein variants refolded with high pressure vs. conventional methods  Identify potential economic benefits of high pressure compared with conventional refolding • Evaluate high pressure for the dissolution of soluble protein aggregates  Using process-related aggregates of a relevant model protein  Show that solubilized monomers have native structure High Pressure Refolding - The Bioprocessing Summit 2015
  • 6. Experimental Approach for Optimization of Process Parameters • Refolding yield: amount of soluble/affinity-captured protein determined • Versatile method needed  suitable for all model proteins and buffers: SDS-PAGE (percent error 13-15%) • First challenge in protein refolding: to limit meaningful experimental space High Pressure Refolding - The Bioprocessing Summit 2015 2-level factorial design • Yield may tend to 0 at extremes of a factor A B „Intuitive raster“ • For 3 levels of 5 factors 35=243 runs A B Optimal design • Requires the smallest number of runs A B
  • 7. Experimental Approach for Optimization of Process Parameters Initial screen (pH, urea, arginine, redox) to limit experimental space Optimization of basic buffer components Additive screen Optimization of other parameters (e.g. Fab chain ratio, additive interactions) Protein concentration and refolding time screen to optimize throughput Scale-up and purification High Pressure Refolding - The Bioprocessing Summit 2015
  • 8. Example for Process Optimization  Fc-Fusion Protein Design-Expert® Software Correlation: 0.129 1 6 11 16 21 26 31 36 41 46 51 0 5 10 15 20 Run Yield(%) High Pressure Refolding - The Bioprocessing Summit 2015 Initial screen at 2 g/L pH 8-10 Urea 0-2 M Tris 0.05-1 M Arg 0-0.5 M Cysteine 0-4 mM Cystine 0-4 mM Parameter optima pH not significant → set to 9.5 2 M Urea 1 MTris 0.4 M Arg 3 mM Cysteine 0 mM Cystine Reduced quadratic model R-Squared 0.6625 Adj R-Squared 0.5935 Pred R-Squared 0.4851 Adeq Precision 10.374 Design-Expert® Software Factor Coding: Actual Original Scale Yield (%) 16.3218 0 X1 = E: Cysteine X2 = F: Cystine Actual Factors A: pH = 9.00 B: Tris = 1.00 C: Urea = 2.00 D: Arg = 0.40 0.0 1.0 2.0 3.0 4.0 0.0 1.0 2.0 3.0 4.0 0 5 10 15 20 25 30 Yield(%) E: Cysteine (mM) F: Cystine (mM) Design-Expert® Software Factor Coding: Actual Original Scale Yield (%) 16.3218 0 X1 = B: Tris X2 = D: Arg Actual Factors A: pH = 9.00 C: Urea = 2.00 E: Cysteine = 3.08 F: Cystine = 1.06 0.00 0.10 0.20 0.30 0.40 0.50 0.05 0.15 0.24 0.34 0.43 0.53 0.62 0.71 0.81 0.90 1.00 0 5 10 15 20 25 30 Yield(%) B: Tris (M) D: Arg (M)
  • 9. Example for Process Optimization  Fc-Fusion Protein High Pressure Refolding - The Bioprocessing Summit 2015 Additive screen at 2 g/L At optimal conditions from initial screen Results Major improvement of yield by applying results of initial screen No significant further improvement by additives ↔ candidates A d d itiv e s Yield(%) B a s e1 lo w1 h ig h2 lo w2 h ig h3 lo w3 h ig h 4 5 6 7 8 9 1 0 1 1 1 2 1 3 1 4 1 5 lo w 1 5 h ig h 1 6 lo w 1 6 h ig h 1 7 lo w 1 7 h ig h 1 8 1 9 2 0 lo w 2 0 h ig h 0 1 0 2 0 3 0 4 0 S a lts D e te rg e n ts O rg a n ic co m p o u n d s
  • 10. Example for Process Optimization  Fc-Fusion Protein High Pressure Refolding - The Bioprocessing Summit 2015 Additive screen at 8 g/L Candidates alone and in combination Additive and pH screen at 8 g/L Results Additive 15 improves yields at higher protein concentrations Higher yields at pH 8.5 A d d itives Yield(%) B a s e1 3 lo w 1 3 h ig h1 5 lo w 1 5 h ig h 4 6 1 2 1 3 lo w + 1 5 lo w 1 3 lo w + 1 5 h ig h 1 3 lo w + 4 1 3 lo w + 6 1 3 lo w + 1 2 1 5 lo w + 4 1 5 lo w + 6 1 5 lo w + 1 2 1 5 h ig h + 4 1 5 h ig h + 6 1 5 h ig h + 1 2 0 5 1 0 1 5 2 0 A d d itiv e s Yield(%) 1 5 h ig h 1 5 h ig h + 6 1 5 h ig h + 1 21 5 h ig h + 1 3 lo w1 5 lo w + 1 3 lo w 0 1 0 2 0 3 0 4 0 p H 9 .5 p H 8 .5
  • 11. High Pressure Refolding Is Readily Scalable • 1 mL caissons → 5-50 mL syringes → ca. 140 mL bioprocess bags High Pressure Refolding - The Bioprocessing Summit 2015 scFv Affinity scaffold 200 66 55 22 14 116 97 kDa Red. IB 140 mL 37 31 6 3.5 1mL 1mL 1mL Std. 200 66 55 22 14 116 97 kDa 37 31 6 1mL 1mL 1mL ReducedIB 5mL 140mL
  • 12. Protein Purification High Pressure Refolding - The Bioprocessing Summit 2015 Affinity scaffoldFab scFv Affinity (ProteinA) CIEX Affinity (ProteinA) CIEX CIEX S E C H P L C T im e (m in ) A214(mAbs) 4 8 1 2 1 6 -3 0 0 0 3 0 0 6 0 0 9 0 0 1 2 0 0 C h a o tro p e H ig h p re s su re 14 200 66 55 22 6 3.5 116 97 kDa 37 31 Chaotrope Highpressure S E C H P L C T im e (m in ) A214(mAbs) 4 8 1 2 1 6 -1 0 0 0 1 0 0 2 0 0 3 0 0 4 0 0 5 0 0 C h a o tro p e H ig h p re s su re 14 200 66 55 22 6 116 97 kDa 37 31 Chaotrope Highpressure S E C H P L C T im e (m in ) A214(mAbs) 4 8 1 2 1 6 -1 0 0 0 1 0 0 2 0 0 3 0 0 4 0 0 C h a o tro p e H ig h p re s su re 14 200 66 55 22 6 3.5 116 97 kDa 37 31 Chaotrope Highpressure Chaotrope: ca. 94% High pressure: ca. 96% Chaotrope: ca. 94% High pressure: ca. 95% Chaotrope: 41-49% High pressure: 50-56%
  • 13. Comparison of Protein Stability and Structure High Pressure Refolding - The Bioprocessing Summit 2015 Affinity scaffoldFab scFv D S C T e m p e ra tu re (°C ) Cp(kcal/mol/°C) 0 2 0 4 0 6 0 8 0 1 0 0 -1 0 0 1 0 2 0 3 0 4 0 5 0 H ig h p re s su re C h a o tro p e C D s p e c tru m  (n m ) [](degcm 2 dmol -1 ) 1 8 0 2 0 0 2 2 0 2 4 0 2 6 0 -6 .0 1 0 5 -4 .0 1 0 5 -2 .0 1 0 5 0 2 .0 1 0 5 4 .0 1 0 5 C h a o tro p e H ig h p re s su re D S C T e m p e ra tu re (°C ) Cp(kcal/mol/°C) 0 2 0 4 0 6 0 8 0 1 0 0 -5 0 5 1 0 1 5 C h a o tro p e H ig h p re s su re C D s p e c tru m  (n m ) [](degcm 2 dmol -1 ) 1 8 0 2 0 0 2 2 0 2 4 0 2 6 0 -4 .0 1 0 5 -2 .0 1 0 5 0 2 .0 1 0 5 4 .0 1 0 5 C h a o tro p e H ig h p re s su re C D s p e c tru m  (n m ) [](degcm 2 dmol -1 ) 1 8 0 2 0 0 2 2 0 2 4 0 2 6 0 -1 .5 1 0 6 -1 .0 1 0 6 -5 .0 1 0 5 0 5 .0 1 0 5 1 .0 1 0 6 C h a o tro p e H ig h p re s su re D S C T e m p e ra tu re (°C ) Cp(kcal/mol/°C) 0 2 0 4 0 6 0 8 0 1 0 0 -2 0 0 2 0 4 0 6 0 C h a o tro p e H ig h p re s su re
  • 14. Comparison of Activity  Fc-Fusion Protein High Pressure Refolding - The Bioprocessing Summit 2015 Strucural studies Fc-receptor binding by SPR -50 0 50 100 150 200 250 -50 0 50 100 150 200 250 300 350 400 RU Response Tim e s -20 0 20 40 60 80 100 120 140 160 180 -50 0 50 100 150 200 250 300 350 400 RU Response Tim e s -50 0 50 100 150 200 250 -50 0 50 100 150 200 250 300 350 400 RU Response Tim e s Sensorsurface Fc-fusion / IgG FcRn Fc-fusion - chaotrope Fc-fusion - high pressure Control - IgG Kd = 35  11 nM Kd = 46  8 nM Kd = 63  3 nM D S C T e m p e ra tu re (°C ) Cp(kcal/mole/°C) 2 0 4 0 6 0 8 0 1 0 0 -5 0 5 1 0 1 5 2 0 2 5 C h a o tro p e H ig h p re s s u re C D s p e c tru m W a v e le n g th (n m ) [](degcm 2 dmol -1 ) 2 0 0 2 2 0 2 4 0 2 6 0 -3 .0 1 0 5 -2 .0 1 0 5 -1 .0 1 0 5 0 1 .0 1 0 5 2 .0 1 0 5 3 .0 1 0 5 C h a o tro p e H ig h p re s s u re
  • 15. Low Population of Aggregate-prone Intermediates Increases Refolding Yields at High Protein Concentrations High Pressure Refolding - The Bioprocessing Summit 2015 M axim al refolding yields P ro te in c o n c e n tra tio n (g /L ) Yield(%) 0 5 1 0 1 5 0 2 0 4 0 6 0 8 0 C h a o tro p e H ig h p re s su re M axim al produ ctivity P ro te in c o n c e n tra tio n (g /L ) Productivity(g/L/h) 0 .1 1 1 0 1 0 0 0 .0 1 0 .1 1 1 0 C h a o tro p e H ig h p re s su re • Fc-fusion protein refolded conventionally and with high pressure
  • 16. High Pressure Refolding Increases Productivity Molecule class Conventional refolding High pressure refolding Increase in productivity Fabs 15% at 0.8 g/L in 30 h 20% at 2 g/L in 6+24 h* 17x 15% at 0.2 g/L in 16 h 6% at 2 g/L in 6 h 11x 3 Fabs not refoldable 3 Fabs not refoldable - scFv 80% at 0.2 g/L in 8 h 40% at 6 g/L in 16 h 8x Other affinity scaffolds 80% at 0.9 g/L in 18 h 50% at 4 g/L in 6 h 8x 10% at 0.1 g/L in 24 h 5% at 2 g/L in 8 h 30x 50% at 1.2 g/L in 24 h 60% at 2 g/L in 2 h 24x Fc-fusions 35% at 0.8 g/L in 3 h 20% at 15 g/L in 2 h 16x 15% at 0.7 g/L in 5 h 50% at 4 g/L in 6 h 16x Other fusion proteins 45% at 1 g/L in 24 h 30% at 30 g/L in 1+8 h* 480x 20% at 1.2 g/L in 12 h 35% at 10 g/L in 1+20 h* 175x 45% at 2 g/L in 14 h 50% at 15 g/L in 1+10 h* 117x High Pressure Refolding - The Bioprocessing Summit 2015 *Time in refolding vessel used for the calculation of productivity
  • 17. Large-scale Manufacturing Feasibility for 2 kg Cleaved and Purified Fusion Protein High Pressure Refolding - The Bioprocessing Summit 2015 Protein mass: 48 kg Titer: 12 g/L Volume: 3,700 L 3 columns Overall yield: 50% Target protein: 2 kg Step yield: 90% Protein mass: 44 kg Step yield: 90% Protein mass: 27 kg Target protein: 4 kg Fusion protein: 12 kg 45% yield at 1 g/L in 24 h 27 kg protein in 27,000 L Max. capacity at BI: 35,000 L 2 cycles at full capacity Target protein: 4 kg Fusion protein: 12 kg 30% yield at 30 g/L in 1+10 h 40 kg protein in 1,300 L Max. capacity : 525 L 3 cycles within 1 day Fermentation IB recovery Purification Fill/finish Solubilization Refolding by dilution Refolding by pressure treatment Step yield: 90% Protein mass: 30 kg Protein mass: 30 kg Titer: 12 g/L Volume: ca. 2,500 L
  • 18. Dissolution of Soluble Protein Aggregates High Pressure Refolding - The Bioprocessing Summit 2015 • Origin of soluble aggregates:  Mammalian cell expression  Protein processing and purification • Fields of application:  Early in downstream processing dissolve large amounts of soluble aggregates formed during expression  Polishing step solubilize trace amounts of aggregates to meet quality criteria • Model protein:  Expressed in CHO cells  Capture pool contains ca. 12% aggregates S E C H P L C c h ro m a to g ra m T im e (m in ) A214(mAU) 2 4 -1 0 0 0 1 0 0 2 0 0 3 0 0 4 0 0 5 0 0 4 6 8 1 0 1 2 A g g re g a te s M o d ifie d m o n o m e rs N a tiv e m o n o m e rs S E C H P L C c h ro m a to g ra m T im e (m in ) A214(mAU) 2 4 -1 0 0 0 1 0 0 2 0 0 3 0 0 4 0 0 5 0 0 4 6 8 1 0 1 2
  • 19. Effects of Pressure and pH High Pressure Refolding - The Bioprocessing Summit 2015 p HAggregatecontent(%) 6 .0 7 .0 8 .0 9 .0 0 5 1 0 1 5 A m b ie n t p re s s u re 2 5 0 0 b a r P re s s u re Aggregatecontent(%) 2 0 0 0 b a r 3 0 0 0 b a r 0 5 1 0 1 5 A m b ie n t p re s s u re H ig h p re s s u re
  • 20. Additives Do Not Improve the Solubilization of Aggregates High Pressure Refolding - The Bioprocessing Summit 2015 A d d itiv e %aggregatesHP/%aggregatesAP b a s e 1 2 3 4 5 6 7 89 lo w9 h ig h 1 0 lo w 1 0 h ig h 1 1 lo w 1 1 h ig h 1 2 lo w 1 2 h ig h 1 3 lo w 1 3 h ig h 1 4 lo w 1 4 h ig h 1 5 1 6 lo w 1 6 h ig h 0 .0 0 0 .2 5 0 .5 0 0 .7 5 1 .0 0 1 .2 5 1 .5 0 D e te rg e n ts O rg a n ic c o m p o u n d s
  • 21. Effects of Pressurization Time and Protein Concentration High Pressure Refolding - The Bioprocessing Summit 2015 P ro te in c o n c e n tra tio n (g /L ) Foldreductionofaggregatecontent 0 .5 1 2 4 0 1 2 3 4 1 6 h 1 h T im e (m in ) A214(mAU) 2 4 -1 0 0 0 1 0 0 2 0 0 3 0 0 4 0 0 5 0 0 4 6 8 1 0 1 2 a g g re g a te s S E C c h ro m a to g ra m s A m b ie n t p re ssu re 3 0 0 0 b a r P ro te in c o n c e n tra tio n (g /L ) Aggregatecontent(%) 0 .5 1 2 4 6 0 5 1 0 1 5 A m b ie n t p re s s u re 1 h a t 3 0 0 0 b a r Are the monomers which were dissolved from aggregates identical to the monomers which have always been monomers?www.clipartbest.com
  • 22. Enrichment of Monomers Dissolved from Aggregates High Pressure Refolding - The Bioprocessing Summit 2015 HIC regeneration pool SEC (S200) purification of aggregates High pressure dissolution of aggregates SEC (S200) purification of monomers S E C H P L C c h ro m a to g ra m s T im e (m in ) A214(mAU) 2 4 -1 0 0 0 1 0 0 2 0 0 3 0 0 4 0 0 5 0 0 6 0 0 4 6 8 1 0 1 2 H IC re g e n e ra tio n p e a k S E C p u rifie d a g g re g a te s H P tre a te d a g g re g a te s S E C p u rifie d m o n o m e rs R e fe re n ce 4 1 % A g g re g a te 2 0 % M o d ifie d 3 9 % M o n o m e r 8 8 % A g g re g a te 8 % M o d ifie d 4 % M o n o m e r 2 0 % A g g re g a te 1 1 % M o d ifie d 6 9 % M o n o m e r 2 % A g g re g a te 9 % M o d ifie d 8 9 % M o n o m e r
  • 23. Monomers Dissolved from Aggregates Are Highly Similar to the Reference Material High Pressure Refolding - The Bioprocessing Summit 2015 S e c o n d a ry s tru c tu re b y C D s p e c tro s c o p y V a w e le n g th (n m ) [](degcm 2 dmol -1 ) 2 0 0 2 2 0 2 4 0 2 6 0 -3 0 0 0 0 0 -2 0 0 0 0 0 -1 0 0 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0 0 R e fe re n c e le s s s trin g e n t c o n d itio n s H P d is s o lv e d le s s s trin g e n t c o n d itio n s R e fe re n c e m o re s trin g e n t c o n d itio n s H P d is s o lv e d m o re s trin g e n t c o n d itio n s
  • 24. Monomers Dissolved from Aggregates Are Highly Similar to the Reference Material High Pressure Refolding - The Bioprocessing Summit 2015 T h e rm a l s ta b ility b y D S C T e m p e ra tu re (°C ) Cp(kcal/mol/°C) 2 0 4 0 6 0 8 0 1 0 0 -1 0 0 1 0 2 0 3 0 R e fe re n c e le s s s trin g e n t c o n d itio n s H P d is s o lv e d le s s s trin g e n t c o n d itio n s R e fe re n c e m o re s trin g e n t c o n d itio n s H P d is s o lv e d m o re s trin g e n t c o n d itio n s T h e rm a l s ta b ility b y in trin s ic flu o re s c e n c e T e m p e ra tu re (°C ) BCMwavelength(nm) 2 0 4 0 6 0 8 0 1 0 0 3 3 0 3 4 0 3 5 0 3 6 0 R e fe re n c e le s s s trin g e n t c o n d itio n s H P d is s o lv e d le s s s trin g e n t c o n d itio n s R e fe re n c e m o re s trin g e n t c o n d itio n s H P d is s o lv e d m o re s trin g e n t c o n d itio n s A g g re g a tio n b y lig h t s c a tte rin g T e m p e ra tu re (°C ) SLS266(counts.nm) 2 0 4 0 6 0 8 0 1 0 0 0 5 0 0 0 0 1 0 0 0 0 0 1 5 0 0 0 0 2 0 0 0 0 0 R e fe re n c e le s s s trin g e n t c o n d itio n s H P d is s o lv e d le s s s trin g e n t c o n d itio n s R e fe re n c e m o re s trin g e n t c o n d itio n s H P d is s o lv e d m o re s trin g e n t c o n d itio n s
  • 25. Summary  Evaluated high pressure for  Refolding a variety of BI‘s model proteins  Dissolution of soluble protein aggregates  Inclusion body refolding:  High pressure increases productivity compared with conventional chaotrope-based techniques  Structure, stability, and activity of proteins refolded with high pressure vs. conventionally are highly comparable  High pressure refolding is readily scalable  High pressure can enable large-scale manufacturing  Aggregate solubilization:  High pressure treatment converts soluble aggregates into native-like monomers High Pressure Refolding - The Bioprocessing Summit 2015
  • 26. Acknowledgement High Pressure Refolding - The Bioprocessing Summit 2015 • Boehringer-Ingelheim RCV Process Science  Susanne Schweiger  Gerald Bieder  Martin Kellner  Srjib Banerjee  Cornelia Walther  Dean Harde  Robert Wandl  Matthias Berkemeyer  Jan Schöning  Wolfgang Buchinger • University of Natural Resources and Life Sciences, Vienna  Alois Jungbauer • BaroFold  Matt Seefeldt